Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2016 Mar;42(3):45-58.
doi: 10.3928/00989134-20160212-08.

Feasibility and Effect Sizes of the Revised Daily Engagement of Meaningful Activities Intervention for Individuals With Mild Cognitive Impairment and Their Caregivers

Randomized Controlled Trial

Feasibility and Effect Sizes of the Revised Daily Engagement of Meaningful Activities Intervention for Individuals With Mild Cognitive Impairment and Their Caregivers

Yvonne Yueh-Feng Lu et al. J Gerontol Nurs. 2016 Mar.

Abstract

A nurse-led intervention, Daily Engagement of Meaningful Activities (DEMA), was evaluated for feasibility and effect sizes in a two-group randomized pilot study with 36 patient-caregiver dyads (17 DEMA and 19 attention control). Effect sizes were estimated on 10 outcomes: dyad functional ability awareness congruence; patients' meaningful activity performance and satisfaction, confidence, depressive symptoms, communication satisfaction, physical function, and life satisfaction; and caregivers' depressive symptoms and life changes. High feasibility of DEMA was supported by the following indicators: consent (97.7%), session completion (91.7%), and Time 3 measure completion (97.2%). Compared to the attention control group, the DEMA group had higher dyad congruence in functional ability awareness and life satisfaction 3 months post-intervention and improved physical function at 2 weeks post-intervention. Although DEMA showed high feasibility and benefits on some health-related outcomes, further testing of DEMA in a larger randomized controlled clinical trial is needed.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Conceptual Framework
Figure 2
Figure 2
Consort Diagram

References

    1. Albert MS, Dekosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, Phelps CH. The diagnosis of mild cognitive impairmentdue toAlzheimer’sdisease: recommendations from the National Institute on Aging -Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Journal of Alzheimer Association: Alzhiemer’s & Demenita. 2011;7(3):270–279. doi:10.1016/j.jalz.2011.03.008. - PMC - PubMed
    1. Alzheimer Association Alzheimer’s disease facts and figures. 2015 Alzheimer’s Disease Facts and Figures. 2015;11(3):332–420. Retrieved from http://www.alz.org/downloads/facts_figures_2015.pdf website: - PubMed
    1. Bakas T, Champion V, Perkins SM, Farran CJ, Williams LS. Psychometric testing of the reivsed 15-item Bakas Caregiving Outcomes Scale. Nursing Research. 2006;55(5):346–355. - PubMed
    1. Barrett AJ, Murk PJ, editors. Life Satisfaction Index for the Third Age-Short Form (LSITA_SF): An improved and briefer measure of successful aging. University of Missouri-St. Louis; St. Louis: 2006.
    1. Bellg AJ, Borrelli B, Resnick B, Hecht J, Minicucci DS, Ory M, Czajkowski S. Enhancing treatment fidelity in health behavior change studies: best practices and recommendations from the NIH Behavior Change Consortium. Healthy Psychology. 2004;23(5):443–451. - PubMed

Publication types